Predicting 10-Year Risk of Pancreatic Cancer Using a Combined Genetic and Clinical Model
Gillian S. Dite(University of Melbourne), Richard Allman(Genetic Technologies (Australia)), Erika L. Spaeth(Bank of America), Chi Kuen Wong(Hong Kong Baptist University), Nicholas M. Murphy(Genetic Technologies (Australia))
Cited by 9
Related Papers
Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
|PLoS ONE|2009|790
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213
Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
|PLoS ONE|2010|175
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
|Human Molecular Genetics|2011|173
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
|The Journal of Experimental Medicine|2016|153